|
| | |
Meeting Record Regarding: Use of Ozone Depleting Substances; Removal of Essential Use Designations
Date: 1/13/2005
| Name |
Affiliation |
Client (if applicable) |
| Richard Rozek |
NERA |
GlaxoSmithKline |
| Emily Bishko |
NERA |
GlaxoSmithKline |
| Paul Noe |
OMB |
|
| John Morrall |
OMB |
|
| Dominic Mancini |
OMB |
|
| Fumie Yokota |
OMB |
|
| Amanda Lee |
OMB |
|
| Randy Lutter |
(by phone) FDA |
|
|
|
|
|